Thomas Anchordoquy
Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liposomes | 26 | 2024 | 231 | 5.130 |
Why?
| | DNA | 31 | 2018 | 1438 | 3.850 |
Why?
| | Gene Transfer Techniques | 12 | 2021 | 176 | 2.990 |
Why?
| | Nanoparticles | 11 | 2024 | 482 | 2.760 |
Why?
| | Cholesterol | 13 | 2019 | 404 | 2.630 |
Why?
| | Lipids | 20 | 2025 | 689 | 2.540 |
Why?
| | Polyethylene Glycols | 12 | 2025 | 639 | 2.270 |
Why?
| | Freeze Drying | 18 | 2014 | 81 | 2.200 |
Why?
| | Drug Carriers | 9 | 2024 | 127 | 2.150 |
Why?
| | Transfection | 21 | 2021 | 936 | 2.090 |
Why?
| | Plasmids | 17 | 2021 | 365 | 2.010 |
Why?
| | Neoplasms | 12 | 2023 | 2718 | 1.790 |
Why?
| | Nanomedicine | 4 | 2024 | 46 | 1.760 |
Why?
| | Exosomes | 5 | 2018 | 105 | 1.550 |
Why?
| | Quaternary Ammonium Compounds | 13 | 2014 | 51 | 1.300 |
Why?
| | Drug Delivery Systems | 7 | 2023 | 360 | 1.240 |
Why?
| | Fatty Acids, Monounsaturated | 12 | 2014 | 54 | 1.210 |
Why?
| | Particle Size | 17 | 2021 | 404 | 1.180 |
Why?
| | Nucleic Acids | 3 | 2015 | 70 | 1.140 |
Why?
| | Polymers | 4 | 2021 | 493 | 0.990 |
Why?
| | Doxorubicin | 3 | 2024 | 358 | 0.950 |
Why?
| | Cell Line, Tumor | 15 | 2025 | 3487 | 0.830 |
Why?
| | Interferons | 1 | 2024 | 195 | 0.800 |
Why?
| | Mice, Inbred BALB C | 8 | 2025 | 1271 | 0.790 |
Why?
| | Phosphatidylcholines | 5 | 2014 | 133 | 0.780 |
Why?
| | Chemistry, Pharmaceutical | 10 | 2014 | 106 | 0.760 |
Why?
| | Animals | 41 | 2025 | 37579 | 0.690 |
Why?
| | COS Cells | 12 | 2009 | 180 | 0.650 |
Why?
| | DNA, Superhelical | 2 | 2011 | 11 | 0.650 |
Why?
| | Drug Stability | 11 | 2020 | 165 | 0.640 |
Why?
| | Phosphatidylethanolamines | 8 | 2014 | 76 | 0.620 |
Why?
| | Tissue Distribution | 5 | 2021 | 327 | 0.620 |
Why?
| | Genetic Vectors | 5 | 2006 | 336 | 0.620 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2019 | 15 | 0.600 |
Why?
| | Receptors, Fc | 1 | 2018 | 56 | 0.560 |
Why?
| | Cytokines | 3 | 2021 | 2092 | 0.550 |
Why?
| | Milk | 1 | 2018 | 123 | 0.550 |
Why?
| | DNA, Circular | 2 | 2011 | 15 | 0.550 |
Why?
| | Carbohydrates | 4 | 2014 | 67 | 0.550 |
Why?
| | Drug Storage | 3 | 2020 | 53 | 0.530 |
Why?
| | Blood Proteins | 3 | 2015 | 250 | 0.530 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 208 | 0.520 |
Why?
| | Freezing | 7 | 2014 | 88 | 0.520 |
Why?
| | Oligopeptides | 1 | 2019 | 275 | 0.520 |
Why?
| | Immunocompetence | 1 | 2016 | 44 | 0.510 |
Why?
| | Mice | 17 | 2025 | 18057 | 0.510 |
Why?
| | Leukocytes | 1 | 2018 | 306 | 0.510 |
Why?
| | Scattering, Radiation | 5 | 2010 | 101 | 0.490 |
Why?
| | Hemolysin Proteins | 2 | 2014 | 35 | 0.480 |
Why?
| | Spermine | 2 | 2006 | 31 | 0.470 |
Why?
| | Antineoplastic Agents | 5 | 2024 | 2156 | 0.470 |
Why?
| | Bacterial Toxins | 2 | 2014 | 104 | 0.460 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 141 | 0.450 |
Why?
| | Granulocytes | 1 | 2015 | 84 | 0.450 |
Why?
| | Sphingosine | 1 | 2014 | 45 | 0.440 |
Why?
| | Azides | 1 | 2014 | 47 | 0.430 |
Why?
| | Alkynes | 1 | 2014 | 64 | 0.430 |
Why?
| | Click Chemistry | 1 | 2014 | 50 | 0.420 |
Why?
| | Complement C3 | 1 | 2015 | 203 | 0.420 |
Why?
| | Calorimetry, Differential Scanning | 6 | 2013 | 37 | 0.410 |
Why?
| | Folic Acid | 2 | 2012 | 198 | 0.400 |
Why?
| | Ferrous Compounds | 1 | 2013 | 24 | 0.400 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 628 | 0.400 |
Why?
| | Microspheres | 2 | 2011 | 142 | 0.400 |
Why?
| | Water | 3 | 2011 | 466 | 0.390 |
Why?
| | Trace Elements | 1 | 2013 | 51 | 0.380 |
Why?
| | Surface Properties | 5 | 2017 | 414 | 0.380 |
Why?
| | Metals | 1 | 2013 | 140 | 0.360 |
Why?
| | Cations | 6 | 2014 | 85 | 0.360 |
Why?
| | Phospholipids | 1 | 2013 | 221 | 0.350 |
Why?
| | Luciferases | 4 | 2017 | 148 | 0.350 |
Why?
| | Reactive Oxygen Species | 3 | 2008 | 632 | 0.340 |
Why?
| | Biological Therapy | 1 | 2011 | 27 | 0.340 |
Why?
| | Surface-Active Agents | 2 | 2009 | 92 | 0.340 |
Why?
| | Bleomycin | 1 | 2012 | 248 | 0.340 |
Why?
| | Gold | 1 | 2011 | 119 | 0.330 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2024 | 131 | 0.310 |
Why?
| | L-Lactate Dehydrogenase | 3 | 2002 | 125 | 0.310 |
Why?
| | Models, Chemical | 1 | 2011 | 272 | 0.310 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2011 | 593 | 0.310 |
Why?
| | Cell Membrane | 1 | 2013 | 720 | 0.300 |
Why?
| | Genetic Therapy | 6 | 2014 | 315 | 0.300 |
Why?
| | MCF-7 Cells | 3 | 2014 | 126 | 0.300 |
Why?
| | Humans | 34 | 2025 | 140898 | 0.300 |
Why?
| | Fluorescent Dyes | 4 | 2018 | 324 | 0.290 |
Why?
| | Trehalose | 4 | 2014 | 33 | 0.280 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4407 | 0.280 |
Why?
| | Liver | 2 | 2015 | 1815 | 0.270 |
Why?
| | Nucleic Acid Conformation | 6 | 2009 | 725 | 0.260 |
Why?
| | Biological Availability | 2 | 2018 | 137 | 0.260 |
Why?
| | Carbocyanines | 3 | 2025 | 37 | 0.260 |
Why?
| | Mice, Nude | 3 | 2017 | 689 | 0.250 |
Why?
| | Cell Line | 4 | 2014 | 2879 | 0.250 |
Why?
| | Ferric Compounds | 1 | 2006 | 55 | 0.250 |
Why?
| | Polydeoxyribonucleotides | 1 | 2006 | 14 | 0.250 |
Why?
| | Endosomes | 2 | 2021 | 144 | 0.250 |
Why?
| | Cattle | 3 | 2018 | 991 | 0.230 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2604 | 0.230 |
Why?
| | Spermidine | 1 | 2005 | 19 | 0.220 |
Why?
| | Dextrans | 1 | 2005 | 85 | 0.220 |
Why?
| | Lipoproteins | 1 | 2025 | 163 | 0.220 |
Why?
| | Extracellular Vesicles | 2 | 2018 | 153 | 0.220 |
Why?
| | Genes, Reporter | 2 | 2017 | 272 | 0.220 |
Why?
| | Sucrose | 4 | 2013 | 111 | 0.210 |
Why?
| | Polyesters | 1 | 2004 | 78 | 0.210 |
Why?
| | Ligands | 2 | 2019 | 667 | 0.210 |
Why?
| | Osmolar Concentration | 3 | 2013 | 167 | 0.200 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2235 | 0.200 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 145 | 0.200 |
Why?
| | Adsorption | 2 | 2013 | 154 | 0.180 |
Why?
| | Glioma | 2 | 2016 | 418 | 0.170 |
Why?
| | Vaccine Potency | 1 | 2020 | 6 | 0.170 |
Why?
| | Lupus Nephritis | 1 | 2021 | 67 | 0.170 |
Why?
| | Excipients | 3 | 2008 | 54 | 0.170 |
Why?
| | Polyethyleneimine | 3 | 2013 | 18 | 0.160 |
Why?
| | Vaccines, Synthetic | 1 | 2020 | 138 | 0.160 |
Why?
| | Lactose | 1 | 2020 | 7 | 0.160 |
Why?
| | Theranostic Nanomedicine | 1 | 2020 | 14 | 0.160 |
Why?
| | Female | 10 | 2025 | 75540 | 0.160 |
Why?
| | RNA, Small Interfering | 2 | 2013 | 624 | 0.160 |
Why?
| | Temperature | 2 | 2013 | 669 | 0.150 |
Why?
| | Nanotechnology | 1 | 2020 | 124 | 0.150 |
Why?
| | Toxicity Tests | 1 | 2019 | 39 | 0.150 |
Why?
| | Thiobarbituric Acid Reactive Substances | 2 | 2008 | 30 | 0.150 |
Why?
| | Oligonucleotides | 2 | 2011 | 147 | 0.150 |
Why?
| | Flow Cytometry | 2 | 2014 | 1195 | 0.140 |
Why?
| | Permeability | 1 | 2018 | 165 | 0.140 |
Why?
| | Solubility | 1 | 2018 | 244 | 0.140 |
Why?
| | Pentetic Acid | 2 | 2008 | 12 | 0.140 |
Why?
| | beta-Galactosidase | 1 | 1997 | 78 | 0.140 |
Why?
| | Chelating Agents | 2 | 2008 | 73 | 0.130 |
Why?
| | Drug Liberation | 1 | 2017 | 35 | 0.130 |
Why?
| | Mice, SCID | 1 | 2018 | 365 | 0.130 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2008 | 25 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2023 | 852 | 0.130 |
Why?
| | Drug Compounding | 1 | 2017 | 104 | 0.130 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 250 | 0.120 |
Why?
| | Administration, Oral | 1 | 2018 | 802 | 0.120 |
Why?
| | Cell Survival | 3 | 2014 | 1129 | 0.120 |
Why?
| | Nebulizers and Vaporizers | 2 | 2006 | 68 | 0.120 |
Why?
| | Astrocytes | 1 | 2018 | 216 | 0.120 |
Why?
| | Ions | 1 | 2015 | 67 | 0.120 |
Why?
| | Tumor Burden | 1 | 2017 | 310 | 0.120 |
Why?
| | Proteins | 2 | 2017 | 1013 | 0.120 |
Why?
| | Alanine Transaminase | 1 | 2015 | 150 | 0.110 |
Why?
| | Circular Dichroism | 2 | 2006 | 148 | 0.110 |
Why?
| | Pharmaceutical Vehicles | 1 | 2014 | 12 | 0.110 |
Why?
| | Kinetics | 3 | 2005 | 1651 | 0.110 |
Why?
| | Glycerylphosphorylcholine | 1 | 2014 | 6 | 0.110 |
Why?
| | Buffers | 2 | 2013 | 56 | 0.110 |
Why?
| | Transition Temperature | 1 | 2014 | 27 | 0.110 |
Why?
| | Nephelometry and Turbidimetry | 2 | 2004 | 15 | 0.110 |
Why?
| | Urate Oxidase | 1 | 2014 | 11 | 0.110 |
Why?
| | Drug Administration Schedule | 1 | 2016 | 766 | 0.110 |
Why?
| | Cycloaddition Reaction | 1 | 2014 | 28 | 0.110 |
Why?
| | Molecular Weight | 2 | 2005 | 327 | 0.110 |
Why?
| | Asparaginase | 1 | 2014 | 30 | 0.110 |
Why?
| | Injections, Intravenous | 1 | 2014 | 201 | 0.110 |
Why?
| | DNA Damage | 2 | 2008 | 429 | 0.110 |
Why?
| | Time Factors | 4 | 2014 | 6944 | 0.110 |
Why?
| | Glioblastoma | 1 | 2018 | 334 | 0.110 |
Why?
| | Polylysine | 1 | 2014 | 17 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 174 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2005 | 188 | 0.110 |
Why?
| | Copper | 1 | 2014 | 115 | 0.100 |
Why?
| | Contrast Media | 1 | 2017 | 470 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 418 | 0.100 |
Why?
| | Choline | 1 | 2014 | 131 | 0.100 |
Why?
| | Dendrimers | 1 | 2013 | 18 | 0.100 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 208 | 0.100 |
Why?
| | Sulfites | 1 | 2013 | 9 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2018 | 699 | 0.100 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 433 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2015 | 374 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 51 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 572 | 0.100 |
Why?
| | Fluoresceins | 1 | 2012 | 49 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2004 | 176 | 0.090 |
Why?
| | KB Cells | 1 | 2012 | 4 | 0.090 |
Why?
| | Luciferases, Firefly | 1 | 2012 | 3 | 0.090 |
Why?
| | Cell Proliferation | 2 | 2018 | 2497 | 0.090 |
Why?
| | Antibodies | 1 | 2014 | 411 | 0.090 |
Why?
| | Binding Sites | 2 | 2006 | 1315 | 0.090 |
Why?
| | Sonication | 1 | 2011 | 12 | 0.090 |
Why?
| | Trastuzumab | 1 | 2012 | 97 | 0.090 |
Why?
| | Extracellular Space | 1 | 2012 | 129 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2005 | 556 | 0.090 |
Why?
| | Cytoplasm | 1 | 2012 | 272 | 0.090 |
Why?
| | Viruses | 1 | 2013 | 163 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 47 | 0.090 |
Why?
| | Thermodynamics | 2 | 2005 | 424 | 0.090 |
Why?
| | Vaccines, DNA | 1 | 2011 | 32 | 0.080 |
Why?
| | Oligonucleotides, Antisense | 1 | 2011 | 110 | 0.080 |
Why?
| | Immunotherapy | 1 | 2015 | 643 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2008 | 1093 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2012 | 179 | 0.080 |
Why?
| | Medulloblastoma | 1 | 2012 | 218 | 0.080 |
Why?
| | DNA, Bacterial | 1 | 2011 | 333 | 0.080 |
Why?
| | Proteomics | 2 | 2016 | 1136 | 0.080 |
Why?
| | Humidity | 1 | 2009 | 50 | 0.080 |
Why?
| | Suspensions | 2 | 2008 | 29 | 0.080 |
Why?
| | Enzyme Stability | 2 | 2001 | 71 | 0.070 |
Why?
| | Methods | 1 | 2008 | 68 | 0.070 |
Why?
| | Stress, Mechanical | 1 | 2011 | 488 | 0.070 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 32 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 903 | 0.070 |
Why?
| | Peptides | 1 | 2014 | 979 | 0.070 |
Why?
| | Energy Transfer | 1 | 2008 | 48 | 0.070 |
Why?
| | Ethidium | 1 | 2008 | 6 | 0.070 |
Why?
| | Clozapine | 1 | 2008 | 21 | 0.070 |
Why?
| | Methionine | 1 | 2008 | 159 | 0.070 |
Why?
| | Luminescence | 1 | 2008 | 37 | 0.070 |
Why?
| | Mice, Knockout | 1 | 2015 | 3064 | 0.070 |
Why?
| | Gelatin | 1 | 2008 | 57 | 0.070 |
Why?
| | Rabbits | 2 | 2001 | 754 | 0.070 |
Why?
| | Static Electricity | 2 | 2006 | 113 | 0.070 |
Why?
| | Serum | 1 | 2008 | 58 | 0.070 |
Why?
| | Fluorescamine | 1 | 2006 | 1 | 0.070 |
Why?
| | Phenanthrolines | 1 | 2006 | 8 | 0.070 |
Why?
| | Deferoxamine | 1 | 2006 | 26 | 0.060 |
Why?
| | Iron Chelating Agents | 1 | 2006 | 19 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 2016 | 1275 | 0.060 |
Why?
| | Edetic Acid | 1 | 2006 | 50 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2015 | 2003 | 0.060 |
Why?
| | Indicators and Reagents | 1 | 2006 | 110 | 0.060 |
Why?
| | Protein Binding | 1 | 2013 | 2238 | 0.060 |
Why?
| | Escherichia coli | 1 | 2011 | 835 | 0.060 |
Why?
| | United States | 1 | 2024 | 15195 | 0.060 |
Why?
| | Light | 2 | 2001 | 395 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 1011 | 0.060 |
Why?
| | Solutions | 1 | 2006 | 168 | 0.060 |
Why?
| | Titrimetry | 1 | 2006 | 12 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 908 | 0.060 |
Why?
| | Entropy | 1 | 2006 | 43 | 0.060 |
Why?
| | Ultrasonics | 1 | 2006 | 50 | 0.060 |
Why?
| | Calorimetry | 1 | 2006 | 71 | 0.060 |
Why?
| | Iron | 1 | 2008 | 323 | 0.060 |
Why?
| | Antipsychotic Agents | 1 | 2008 | 208 | 0.060 |
Why?
| | Hydrogen Bonding | 1 | 2006 | 168 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 985 | 0.060 |
Why?
| | Nucleic Acid Denaturation | 1 | 2005 | 32 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1471 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2008 | 1086 | 0.060 |
Why?
| | Aerosols | 1 | 2006 | 180 | 0.060 |
Why?
| | Absorption | 1 | 2004 | 61 | 0.060 |
Why?
| | Molecular Structure | 1 | 2006 | 501 | 0.050 |
Why?
| | Behavior, Animal | 1 | 2008 | 515 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 203 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4127 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 2006 | 168 | 0.050 |
Why?
| | Schizophrenia | 1 | 2008 | 441 | 0.050 |
Why?
| | Lactic Acid | 1 | 2004 | 303 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2003 | 140 | 0.050 |
Why?
| | Shear Strength | 1 | 2002 | 68 | 0.050 |
Why?
| | Base Sequence | 1 | 2006 | 2169 | 0.050 |
Why?
| | Phosphates | 1 | 2002 | 179 | 0.040 |
Why?
| | Salts | 1 | 2001 | 37 | 0.040 |
Why?
| | Glycine | 1 | 2002 | 185 | 0.040 |
Why?
| | Imatinib Mesylate | 1 | 2021 | 79 | 0.040 |
Why?
| | Protein Structure, Quaternary | 1 | 2001 | 120 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 85 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1968 | 0.040 |
Why?
| | Surface Tension | 1 | 2000 | 10 | 0.040 |
Why?
| | Mannitol | 1 | 2000 | 37 | 0.040 |
Why?
| | Cell Movement | 2 | 2018 | 982 | 0.040 |
Why?
| | Isoenzymes | 1 | 2001 | 301 | 0.040 |
Why?
| | Protein Subunits | 1 | 2001 | 228 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 333 | 0.040 |
Why?
| | RNA Stability | 1 | 2020 | 116 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2001 | 801 | 0.040 |
Why?
| | Models, Molecular | 1 | 2004 | 1602 | 0.040 |
Why?
| | Cold Temperature | 1 | 2020 | 196 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2002 | 837 | 0.040 |
Why?
| | Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2002 | 1361 | 0.040 |
Why?
| | Swine | 1 | 2001 | 809 | 0.040 |
Why?
| | Povidone | 1 | 1996 | 4 | 0.030 |
Why?
| | Serum Albumin, Bovine | 1 | 1996 | 66 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 60 | 0.030 |
Why?
| | Myocardium | 1 | 2001 | 927 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2015 | 56 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 4199 | 0.030 |
Why?
| | Kidney | 1 | 2021 | 1475 | 0.030 |
Why?
| | Interferon-alpha | 1 | 2014 | 196 | 0.030 |
Why?
| | Protein Conformation | 1 | 1996 | 939 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2016 | 740 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2822 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2012 | 14 | 0.020 |
Why?
| | Glucose | 1 | 1997 | 1031 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2008 | 2522 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2003 | 87 | 0.020 |
Why?
| | Complement Activation | 1 | 2014 | 415 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3172 | 0.020 |
Why?
| | Rats | 2 | 2008 | 5594 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2008 | 7 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 2008 | 55 | 0.020 |
Why?
| | beta-Cyclodextrins | 1 | 2008 | 33 | 0.020 |
Why?
| | Maze Learning | 1 | 2008 | 103 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 200 | 0.020 |
Why?
| | Neurotoxicity Syndromes | 1 | 2008 | 39 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2008 | 89 | 0.020 |
Why?
| | Reflex, Startle | 1 | 2008 | 72 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 97 | 0.020 |
Why?
| | Drug Design | 1 | 2008 | 168 | 0.020 |
Why?
| | Evoked Potentials, Auditory | 1 | 2008 | 179 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2008 | 324 | 0.020 |
Why?
| | Iodides | 1 | 2006 | 11 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2008 | 887 | 0.010 |
Why?
| | NF-kappa B | 1 | 2008 | 690 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2006 | 594 | 0.010 |
Why?
| | Desiccation | 1 | 2003 | 22 | 0.010 |
Why?
| | Ammonium Sulfate | 1 | 2002 | 13 | 0.010 |
Why?
| | Protein Denaturation | 1 | 2002 | 73 | 0.010 |
Why?
| | Male | 3 | 2021 | 69893 | 0.010 |
Why?
| | Crystallization | 1 | 2002 | 146 | 0.010 |
Why?
| | Hippocampus | 1 | 2008 | 939 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5148 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2003 | 368 | 0.010 |
Why?
| | Glycerophospholipids | 1 | 2000 | 36 | 0.010 |
Why?
| | Colloids | 1 | 2000 | 61 | 0.010 |
Why?
| | Vibration | 1 | 2000 | 72 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2003 | 525 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2002 | 789 | 0.010 |
Why?
|
|
Anchordoquy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|